Thursday - October 22, 2020
Rutgers Named Study Site for Monitoring, Predicting Kidney Risk in COVID-19 Patients
October 15, 2020
NEW BRUNSWICK, New Jersey, Oct. 15 (TNSRes) -- Rutgers University issued the following news:

Rutgers New Jersey Medical School will be a clinical test site for a study assessing the long term risk of chronic kidney disease in patients who recover from COVID-19.

The Multi-Center Assessment of Survivors for Kidney Disease after COVID-19 (MASKeD-COVID) study - conducted by the Division of Nephrology at Mount Sinai - will assess risk in up to 4,000 patients who have recover . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Name:
What's your
Affiliation
Government Newspaper / Media Business
Public Policy Individual / Student Educators
Email:
Phone:
Organization, if any:
State/Country you are in:
Additonal questions
or comments:

Click here for more information about our products

Click here for more information about our products